Design and evaluation of Trypanosoma brucei metacaspase inhibitors

Berg, M. et al. (2010) Design and evaluation of Trypanosoma brucei metacaspase inhibitors. Bioorganic and Medicinal Chemistry Letters, 20(6), pp. 2001-2006. (doi: 10.1016/j.bmcl.2010.01.099)

[img] Text


Publisher's URL:


Metacaspase (MCA) is an important enzyme in <i>Trypanosoma brucei</i>, absent from humans and differing significantly from the orthologous human caspases. Therefore MCA constitutes a new attractive drug target for antiparasitic chemotherapeutics, which needs further characterization to support the discovery of innovative drug candidates. A first series of inhibitors has been prepared on the basis of known substrate specificity and the predicted catalytic mechanism of the enzyme. In this Letter we present the first inhibitors of TbMCA2 with low micromolar enzymatic and antiparasitic activity in vitro combined with low cytotoxicity.

Item Type:Articles
Glasgow Author(s) Enlighten ID:Moss, Dr Catherine and Mottram, Professor Jeremy and Coombs, Professor Graham and Rudolf, Dr Jana
Authors: Berg, M., Van der Veken, P., Joossens, J., Muthusamy, V., Breugelmans, M., Moss, C. X., Rudolf, J., Cos, P., Coombs, G. H., Maes, L., Haemers, A., Mottram, J. C., and Augustyns, K.
Subjects:Q Science > QH Natural history > QH345 Biochemistry
College/School:College of Medical Veterinary and Life Sciences > School of Infection & Immunity
Journal Name:Bioorganic and Medicinal Chemistry Letters
ISSN (Online):1464-3405
Published Online:25 January 2010
Related URLs:

University Staff: Request a correction | Enlighten Editors: Update this record

Project CodeAward NoProject NamePrincipal InvestigatorFunder's NameFunder RefLead Dept
241291Molecular Genetic and Biochemical Analyses of ParasitesJeremy MottramMedical Research Council (MRC)G97222968Infection Immunity and Inflammation Life Sciences
454141Analysing the roles of petidases in Leishmania infectivity and pathogenicityJeremy MottramMedical Research Council (MRC)G0700127Infection Immunity and Inflammation Life Sciences